Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT)

Detalles Bibliográficos
Autores principales: Gilchrist, Mark, Jamieson, Conor, Drummond, Felicity, Hills, Tim, Seaton, R Andrew, Santillo, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108881/
https://www.ncbi.nlm.nih.gov/pubmed/37077650
http://dx.doi.org/10.1093/jacamr/dlad047
_version_ 1785026934834462720
author Gilchrist, Mark
Jamieson, Conor
Drummond, Felicity
Hills, Tim
Seaton, R Andrew
Santillo, Mark
author_facet Gilchrist, Mark
Jamieson, Conor
Drummond, Felicity
Hills, Tim
Seaton, R Andrew
Santillo, Mark
author_sort Gilchrist, Mark
collection PubMed
description
format Online
Article
Text
id pubmed-10108881
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101088812023-04-18 Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT) Gilchrist, Mark Jamieson, Conor Drummond, Felicity Hills, Tim Seaton, R Andrew Santillo, Mark JAC Antimicrob Resist Correspondence Oxford University Press 2023-04-17 /pmc/articles/PMC10108881/ /pubmed/37077650 http://dx.doi.org/10.1093/jacamr/dlad047 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Correspondence
Gilchrist, Mark
Jamieson, Conor
Drummond, Felicity
Hills, Tim
Seaton, R Andrew
Santillo, Mark
Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT)
title Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT)
title_full Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT)
title_fullStr Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT)
title_full_unstemmed Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT)
title_short Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT)
title_sort assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (opat)
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108881/
https://www.ncbi.nlm.nih.gov/pubmed/37077650
http://dx.doi.org/10.1093/jacamr/dlad047
work_keys_str_mv AT gilchristmark assessmentofceftolozanetazobactamdegradationprofileandtoxicitydatainelastomericdevicesforcontinuousinfusionviaoutpatientparenteralantimicrobialtherapyopat
AT jamiesonconor assessmentofceftolozanetazobactamdegradationprofileandtoxicitydatainelastomericdevicesforcontinuousinfusionviaoutpatientparenteralantimicrobialtherapyopat
AT drummondfelicity assessmentofceftolozanetazobactamdegradationprofileandtoxicitydatainelastomericdevicesforcontinuousinfusionviaoutpatientparenteralantimicrobialtherapyopat
AT hillstim assessmentofceftolozanetazobactamdegradationprofileandtoxicitydatainelastomericdevicesforcontinuousinfusionviaoutpatientparenteralantimicrobialtherapyopat
AT seatonrandrew assessmentofceftolozanetazobactamdegradationprofileandtoxicitydatainelastomericdevicesforcontinuousinfusionviaoutpatientparenteralantimicrobialtherapyopat
AT santillomark assessmentofceftolozanetazobactamdegradationprofileandtoxicitydatainelastomericdevicesforcontinuousinfusionviaoutpatientparenteralantimicrobialtherapyopat

Ejemplares similares